Search
Enter keywords, a title or a report id number below.
Your Search for 'Chugai: Pipeline, Products, Performance and Potential' returned 27 results - Page 1 of 2
Sort by
Sorted by
Rank
Top-Bottom
-
Global Pharmaceutical & Biotechnology Outlook 2013: Japan Pharma
MP Advisors, Jan 2013 , Pages: 146. Mitsubishi Tanabe - Key Milestones 36. Mitsubishi Tanabe – SGLT2 Pipeline (Japan And Global Status) 37. Mitsubishi Tanabe – SGLT2 Inhibitors- Clinical Data Comparison 38. Mitsubishi Tanabe - Key Products 39 ... -
Chugai Pharmaceutical Co., Ltd. (4519) - Financial and Strategic SWOT Analysis Review
GlobalData, May 2011 , Pages: 38- Limited Investor Confidence Chugai Pharmaceutical Co., Ltd. - Opportunities Opportunity - Products in Pipeline Opportunity - Growth in Emerging Markets Opportunity - Market Potential: Oncology ... -
Top 50 Pharmaceutical Companies & Their Pipelines 2011
UBM Canon, Sep 2011 , Pages: 234U.S. and EU as well as FDA approval for generic Enoxaparin. The Swiss company has at least seven more potential blockbusters in the pipeline. The following information is included for the top 50 ... -
F. Hoffmann-La Roche Ltd.: PharmaVitae Profile
Datamonitor, Jul 2010 , Pages: 117company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually ... -
Genzyme Corporation: PharmaVitae Profile
Datamonitor, Aug 2010 , Pages: 98global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. Features and benefits - Gain insight into Genzyme's ... -
Tarceva (Pancreatic Cancer) - Analysis and Forecasts to 2020
GlobalData, Dec 2011 , Pages: 35, and analysis of sales performance during the forecast period (2005-2020). The report also includes information on Pancreatic Cancer market. This report is built using data and information sourced from ... -
Kissei Pharmaceutical Co., Ltd. (4547) - Financial and Strategic SWOT Analysis Review
GlobalData, Mar 2013 , Pages: 34. Competitive and/or technological threats are highlighted. Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance ... -
CanBas Co., Ltd. (4575) - Financial and Strategic SWOT Analysis Review
GlobalData, Mar 2013 , Pages: 30are highlighted. Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. - Financial ratio presented for ... -
Eisai Co., Ltd. (4523) - Financial and Strategic SWOT Analysis Review
GlobalData, Mar 2013 , Pages: 53technological threats are highlighted. Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. - Financial ratio ... -
Taiho Pharmaceutical Co., Ltd. - Strategic SWOT Analysis Review
GlobalData, Feb 2012 , Pages: 25Pharmaceutical Co., Ltd. - Key Employees Taiho Pharmaceutical Co., Ltd. - Major Products and Services Taiho Pharmaceutical Co., Ltd. - Pharmaceutical Pipeline Products Data Taiho Pharmaceutical Co., Ltd ... -
Global Biopharma Outlook 2011
MP Advisors, Jan 2011 , Pages: 391- Du Pont Analyses of Indian Companies - FIIs Holdings - Change in Shareholding - NCE and Biologic pipeline of Indian Companies Global Pharma: Macro View 2010 Performance - 2010 - A Year of ... -
Teijin Limited Petrochemicals Capacity and SWOT Analysis
GlobalData, Aug 2011 , Pages: 50Widespread Geographic Presence Strong Financial Performance Sturdy Research and Development Activities Teijin Limited Weaknesses Geographical Concentration Teijin Limited Opportunities Product Pipeline ... -
Avastin (Breast Cancer) - Analysis and Forecasts to 2020
GlobalData, Dec 2011 , Pages: 47, Breast cancer, Bevacizumab, Sales forecast, VEGF Inhibitor, Phase III, Phase 3, Pipeline, competitors to Gemzar, Xeloda, Taxotere and Arimidex, Genentech/Roche/Chugai, , Targeted therapy, Branded 1 ... -
Avastin (Ovarian Cancer) - Analysis and Forecasts to 2020
GlobalData, Sep 2011 , Pages: 33analysis of sales performance during the forecast period (2011-2020). The report also includes information on Ovarian Cancer market. This report is built using data and information sourced from GlobalData’s ... -
Shionogi & Co., Ltd. (4507) - Financial and Strategic SWOT Analysis Review
GlobalData, Apr 2012 , Pages: 139Diagnostics. The company currently has 18 pipeline products in undergoing clinical trials. The company holds 17 subsidiaries and two distribution centers, namely, Shionogi Distribution Center, Osaka and ... -
Monoclonal Antibodies 2007: Competitive Landscape & Pipeline Insight
Arrowhead Publishers, Jan 2007 , Pages: 158of future generic competition - are assessed to provide a balanced overview of the market and key products by major therapeutic categories. Finally, the report forecasts likely revenue performance of ... -
Mitsubishi Tanabe Pharma Corporation (4508) - Financial and Strategic SWOT Analysis Review
GlobalData, Apr 2012 , Pages: 40company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and ... -
Amgen Inc. (AMGN) - Financial and Strategic SWOT Analysis Review
GlobalData, Mar 2013 , Pages: 66technological threats are highlighted. Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. - Financial ratio ... -
Takeda Pharmaceutical Company Limited (4502) - Financial and Strategic SWOT Analysis Review
GlobalData, Mar 2013 , Pages: 59technological threats are highlighted. Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. - Financial ratio ... -
Ono Pharmaceutical Co., Ltd. (4528) - Financial and Strategic SWOT Analysis Review
GlobalData, Apr 2013 , Pages: 39its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key ...
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
